tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lee, 75 are a BUY (88.24%), 10 are a HOLD (11.76%).
Analyst Sean Lee, carries an average stock price target met ratio of 27.7% that have a potential upside of 36.39% achieved within 117 days. Previously, Sean Lee worked at HCWAINWRIGHT.
Sean Lee’s has documented 159 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on KZIA, Kazia Therapeutics Ltd ADR at 12-Dec-2025.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 1/22/2025. The price target of $40 was fulfilled within 2 days with a profit of $6.33 (18.8%) receiving and performance score of 94.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 22-May-2023
$4
$2.9 (263.64%)
$4
4 months 12 days ago
(03-Sep-2025)
1/7 (14.29%)
$1.67 (71.67%)
54
Buy
Since 17-May-2021
$4
3 years 1 months 30 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy
Since 24-Mar-2020
$12
$10.9 (990.91%)
3 years 5 months ago
(15-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
3 years 7 months 20 days ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
Which stock is Sean Lee is most bullish on?
Which stock is Sean Lee is most reserved on?
What Year was the first public recommendation made by Sean Lee?
